This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brismar J, Gustafson T. Bone scintigraphy in staging of bladder carcinoma. Acta Radiol. 1988;29(2):251–2.
Davey P, Merrick MV, Duncan W, Redpath AT. Bladder cancer: the value of routine bone scintigraphy. Clin Radiol. 1985;36(1):77–9.
Sauerbrunn BJ, Andrews GA, Hubner KF. Ga-67 citrate imaging in tumors of the genito-urinary tract: report of cooperative study. J Nucl Med. 1978;19(5):470–5.
Yang CC, Shiau YC, Sun SS, Kao CH. Detection of bladder cancer using single-photon emission computed tomography of thallium-201: a preliminary report. Anticancer Res. 2003;23(3C):2977–80.
Yu LZ, Gu FL, Zhang CL. Radioimmunoimaging diagnosis of human bladder carcinoma. Scand J Urol Nephrol Suppl. 1994;157:13–7.
Malamitsi J, Zorzos J, Varvarigou AD, Archimandritis S, Dassiou C, Skarlos DV, et al. Immunolocalization of transitional cell carcinoma of the bladder with intravesically administered technetium-99m labelled HMFG1 monoclonal antibody. Eur J Nucl Med. 1995;22(1):25–31.
Simms MS, Perkins AC, Price MR, Scholfield DP, Bishop MC. 99mTechnetium-C595 radioimmunoscintigraphy: a potential staging tool for bladder cancer. BJU Int. 2001;88(7):686–91.
Harney JV, Wahl RL, Liebert M, Kuhl DE, Hutchins GD, Wedemeyer G, et al. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography. J Urol. 1991;145(2):279–83.
Bachor R, Kocher F, Gropengiesser F, Reske SN, Hautmann RE. Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results. Urologe A. 1995;34(2):138–42.
Bachor R, Kotzerke J, Reske SN. Lymph node staging of bladder neck carcinoma with positron emission tomography. Urologe A. 1999;38:46–50.
Heicappell R, Muller-Mattheis V, Reinhardt M. Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose. Eur Urol. 1999;36:582–7.
Kosuda S, Kison PV, Greenough R. Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med. 1997;24:615–20.
Kubota R, Kubota K, Yamada S, Tada M, Takahashi T, Iwata R, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med. 1995;36(3):484–92.
Ahlstrom H, Malmstrom PU, Letocha H. Positron emission tomography in the diagnosis and staging of urinary bladder cancer. Acta Radiol. 1996;37:180–85.
Ratnam S, Kent C. Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines. Arch Biochem Biophys. 1995;323:313–322.
Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res. 2001;61(9):3599–603.
Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res. 1996;16:1375–1380.
Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med. 1997;38(6):842–7.
de Jong IJ, Pruim J, Elsinga PH, Jongen MM, Mensink HJ, Vaalburg W. Visualisation of bladder cancer using (11)C-choline PET: first clinical experience. Eur J Nucl Med Mol Imaging. 2002;29(10):1283–8.
Hara T. 18F-fluorocholine: a new oncologic PET tracer. J Nucl Med. 2001;42(12):1815–7.
Ficarra V, Dalpiaz O, Alrabi N, Novara G, Galfano A, Artibani W. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int. 2005;95(6):786–90.
Schoder H, Erdi YE, Larson SM, et al. PET/CT: a new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging. 2003;30:1419–37.
Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med. 2003;44:1200–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag London Limited
About this chapter
Cite this chapter
Ham, H., van de Wiele, C. (2009). Urothelial Cell Carcinoma in Lower Urinary Tract: Radionuclide Imaging. In: de la Rosette, J.J., Manyak, M.J., Harisinghani, M.G., Wijkstra, H. (eds) Imaging in Oncological Urology. Springer, London. https://doi.org/10.1007/978-1-84628-759-6_18
Download citation
DOI: https://doi.org/10.1007/978-1-84628-759-6_18
Publisher Name: Springer, London
Print ISBN: 978-1-84628-514-1
Online ISBN: 978-1-84628-759-6
eBook Packages: MedicineMedicine (R0)